Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.

Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors. J Control Release. 2015 Oct 28; 216:103-10.

View in: PubMed

subject areas

Animals
Antineoplastic Agents, Phytogenic
Cell Line, Tumor
Drug Delivery Systems
Drug Resistance, Neoplasm
Female
Gene Silencing
Genetic Therapy
Humans
Inhibitor of Apoptosis Proteins
Injections, Intravenous
Lipids
Mice
Mice, Nude
Paclitaxel
Pancreatic Neoplasms
Peritoneal Neoplasms
RNA, Neoplasm
RNA, Small Interfering
Transfection
Xenograft Model Antitumor Assays

authors with profiles

David J. Cole